FDA Drug Application (017875) for LOESTRIN 21 1.5/30 by APIL

Back to FDA Applications sponsored by APIL

Application Number017875
Product Number001
FormTABLET;ORAL-21
Dosage0.03MG;1.5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLOESTRIN 21 1.5/30
Active IngredientETHINYL ESTRADIOL; NORETHINDRONE ACETATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORETHINDRONE ACETATE56


Back to FDA Applications sponsored by APIL